A navigator for the family through the first 60 days after a cancer diagnosis
TL;DR Fordwise assigns a trained navigator to a family in the weeks after a cancer diagnosis. The navigator books tests, gathers records, chases insurance and scheme approvals and keeps one shared plan. Families pay a fixed fee for 60 days, and employers can buy it as a benefit. It never gives medical advice.
India recorded about 15.6 lakh new cancer cases in 2024 and 9 lakh deaths[1]. Most families meet the system cold, with no idea who to call first. A 2026 review of 30 Indian studies grouped the reasons people delay care into eight kinds of barrier, from money and stigma to slow, confusing hospitals, and named patient navigation as one fix[2].
Paperwork alone can cost a family dearly. In a 2026 Tamil Nadu radiotherapy study, insured patients who did not use their cover faced catastrophic costs, with a median of ₹55,900[3]. Travel and lodging added to the bill even when treatment itself was covered[3]. And here's the sad bit - nobody in that chain works for the family.
What it does, in regulatory terms: non-clinical navigation and administrative support only. Fordwise does not screen, diagnose, recommend treatment or interpret reports. Every medical decision stays with the treating oncologist or a partner hospital's doctors.
A family signs up the week of diagnosis. Within a day, a navigator with a nursing or social-work background calls, lists every pending test and appointment, and builds a shared plan the family can see on a chat app. The navigator pulls records with consent, chases pre-authorisation with the insurer or scheme desk, finds lodging near the treating centre and flags anything that has stalled for more than three days.
I've reframed the seed, which pitched AI insights across all of healthcare. That's unfocused and slides toward medical advice. Cancer has the clearest evidence for navigation, since in a 2025 trial navigated patients started treatment in 19 days against 28, though survival did not change[4]. So Fordwise sells speed and less chaos, and it shouldn't promise better outcomes.
The patient is the user. The payer is usually an adult child or spouse, often living in another city. A fixed 60-day fee of ₹15,000–30,000 is my assumption, set below what families report spending on a single trip for a second opinion - one second-opinion service says remote opinions save ₹81,000–1,80,000 in travel[5]. Employers and group insurers are the second buyer, paying a per-case fee as a benefit for staff and their parents.
GLOBOCAN's 2024 figures for India, published in September 2026, show cases rising[1]. An alliance backed by a major US cancer charity issued a global call in August 2026 to make navigation a standard part of cancer care[6]. ABDM has issued more than 93.95 crore health IDs, with 105 crore records linked by July 2026[7], so consent-based record pulls are becoming practical.
There is no public figure for paid cancer navigation in India. The firm number is volume, at about 15.6 lakh new diagnoses a year[1]. If 1% of those families paid ₹20,000 then that would be roughly ₹31 Cr a year, which is my arithmetic and not a market estimate. That service's travel-savings claim[5] shows families already spend heavily on getting the first plan right.
Second-opinion services sell expert treatment opinions from Tata Memorial and National Cancer Grid doctors, and a patient advocate calls within a day[5]. That covers the medical plan, not the weeks of logistics after it. Some large hospitals run their own navigators, but they work for that hospital. Abroad, a major US cancer charity funds navigators and leads a global alliance on the model[6]. The gap in India is a navigator who works for the family across hospitals, labs and payers.
| Difficulty | Moderate (37/100) |
| Starting capital | ₹45–85 L |
| Time to launch | 4–6 months |
The software is simple. The hard part is people - hiring navigators who stay calm with frightened families, training them to stop short of medical advice and keeping each caseload small enough to be useful. Getting referrals is the other problem, because families need you in the week of diagnosis and that's the one week they rarely go looking for help.
I found no licence that covers non-clinical navigation. The legal limits are on medical advice and health data.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
AI must never interpret a report, suggest a treatment or rank hospitals on clinical grounds. Fordwise is logistics and paperwork, not diagnosis or treatment, and every medical question goes back to the doctors.
Want to work out the AI layer for Fordwise? Talk to Yash →
Here's what can go south -
I think this suits a founder with hospital operations or patient-services experience who can hire and train a calm team. If you're hoping to build an app and scale without staff then it is a poor fit. Before raising money, prove two things - that 30 families will pay the full fee and that navigated cases reach their first treatment visibly faster.
The free Fordwise validation kit has the line-by-line capital breakdown, the effort scoring, the consent and scope checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for families and employers, and 5 assumptions to test. Download the kit →
Thinking about building Fordwise or something close to it? The make-or-break work is getting referred into a family's life in the week of diagnosis and keeping navigators inside a non-clinical scope, and that's the sort of thing I help founders think through. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.